Cantourage Group SEXTER:HIGH -1.60%29 Market Cap is €69.35 Mil as of Jun. 29, 2026. GuruFocus rates XTER:HIGH with a GF Score™ of 29/100. The stock has 4 warning signs investors should review. Among 1,020 Drug Manufacturers companies, Cantourage Group SE ranks worse than 63.04% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cantourage Group SE's share price for the quarter that ended in Jun. 2025 was €5.46. Cantourage Group SE's Shares Outstanding (EOP) for the quarter that ended in Jun. 2025 was 12.47 Mil. Therefore, Cantourage Group SE's market cap for the quarter that ended in Jun. 2025 was €68.07 Mil.
Cantourage Group SE's quarterly market cap
declined
from Dec. 2023 (€89.51 Mil) to Jun. 2024 (€84.78 Mil) and
declined
from Jun. 2024 (€84.78 Mil) to Jun. 2025 (€68.07 Mil).
Cantourage Group SE's annual market cap
increased
from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€176.28 Mil) but then
declined
from Dec. 2022 (€176.28 Mil) to Dec. 2023 (€89.51 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cantourage Group SE's Enterprise Value for Today is €68.33 Mil.
Cantourage Group SE (XTER:HIGH) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cantourage Group SE Market Cap Related Terms
Cantourage Group SE Market Cap Historical Data
* Premium members only.
The historical data trend for Cantourage Group SE's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:HIGH vs ZTS, UTHR, VTRS: Market Cap Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cantourage Group SE Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Market Cap distribution charts can be found below:
* The bar in red indicates where Cantourage Group SE's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cantourage Group SE's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cantourage Group SE (XTER:HIGH) has a Market Cap of €69.35 Mil as of Jun. 29, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cantourage Group SE and its competitors. According to the industry distribution chart, Cantourage Group SE ranks #643 out of 1020 companies in the Drug Manufacturers industry, placing it in the top 63%.
Is Cantourage Group SE's Market Cap too high?
Cantourage Group SE's current Market Cap is €69.35 Mil. Based on the distribution chart, Cantourage Group SE ranks #643 out of 1020 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cantourage Group SE has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Market Cap compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #643 out of 1020 companies for Market Cap. This places Cantourage Group SE in the lower half of its industry. The industry median Market Cap is 206.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 206.61, based on 1,020 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median Market Cap is 206.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current Market Cap is €69.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current Market Cap of €69.35 Mil. The current Market Cap is €69.35 Mil. Cantourage Group SE's overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current Market Cap is €69.35 Mil as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
29GF Score
Get the complete analysis for XTER:HIGH
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:HIGH has been successfully added to your 
